| Title: | Glutathione transferase P1-1 as an arsenic drug-sequestering enzyme |
| Authors: | Parker, LJ Bocedi, A Ascher, DB Aitken, JB Harris, HH Lo Bello, M Ricci, G Morton, CJ Parker, MW |
| Issue Year: | 2017 |
| Publisher | WILEY-BLACKWELL |
| Series | Protein Sci.: |
| Abstract | Arsenic-based compounds are paradoxically both poisons and drugs. Glutathione transferase (GSTP1-1) is a major factor in resistance to such drugs. Here we describe using crystallography, X-ray absorption spectroscopy, mutagenesis, mass spectrometry, and kinetic studies how GSTP1-1 recognizes the drug phenylarsine oxide (PAO). In conditions of cellular stress where glutathione (GSH) levels are low, PAO crosslinks C47 to C101 of the opposing monomer, a distance of 19.9 angstrom, and causes a dramatic widening of the dimer interface by approximately 10 angstrom. The GSH conjugate of PAO, which forms rapidly in cancerous cells, is a potent inhibitor (K-i=90 nM) and binds as a di-GSH complex in the active site forming part of a continuous network of interactions from one active site to the other. In summary, GSTP1-1 can detoxify arsenic-based drugs by sequestration at the active site and at the dimer interface, in situations where there is a plentiful supply of GSH, and at the reactive cysteines in conditions of low GSH. PDB Code(s): ; ; ; |
| URI: | https://publications.svi.edu.au/publications/6331 |
| Other Identifiers | 10.1002/pro.3084 |
| Publication type | Article |